ホーム › PubMed Lab 🤖 自分の AI で使う ⭐ 保存した論文

🔬 PubMed Lab

日本語で入力するだけで、PubMed の英語論文を検索できるリサーチアシスタントです。
卒論・研究テーマ探し、興味のある論文を効率よく見つけられます。

「ADHD治療薬の副作用パターン、7剤を比較」の検索結果

536 件中 10 件を表示 (5817 ms) · ⭐ 保存した論文

AI が生成した英語クエリを見る
("Attention Deficit Disorder with Hyperactivity"[MeSH] OR ADHD) AND ("Central Nervous System Stimulants"[MeSH] OR methylphenidate OR amphetamine OR atomoxetine OR guanfacine OR clonidine OR lisdexamfetamine OR viloxazine) AND ("Drug-Related Side Effects and Adverse Reactions"[MeSH] OR "adverse effects"[Subheading] OR side effects OR safety OR tolerability) AND (comparative study OR comparison)

💡 ADHD治療薬の主要7剤(メチルフェニデート、アンフェタミン系、アトモキセチン、グアンファシン、クロニジン、リスデキサンフェタミン、ビロキサジン)と副作用・比較研究を組み合わせたクエリ

🎓 卒論・修論テーマを AI が提案

この 5 本の論文を俯瞰して、あなたが実際に卒論・修論で研究できるテーマを 3 つ提案します。

残り 3 / 3 回 (今日)

📖 このサイトの解説記事から (日本語で読める)

PubMed Trivia が過去に取り上げた論文を日本語で解説している記事です。

🔍 PubMed の検索結果

  • Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.

    Samuele Cortese, Nicoletta Adamo, Cinzia Del Giovane 他 · The lancet. Psychiatry · 2018

    The benefits and safety of medications for attention-deficit hyperactivity disorder (ADHD) remain controversial, and guidelines are inconsistent on which medications are preferred across different age groups. We aimed to estimate the comparative efficacy and tolerability of oral medications for ADHD in children, adolescents, and adults. We did a literature search for published and unpublished doub…

    📄 PubMed で読む (PMID: 30097390)
  • Comparative pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine-A literature review.

    Wolfgang Kämmerer · Human psychopharmacology · 2024

    To compare the pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine (LDX). A search of Medline and Embase was conducted to identify relevant articles for this literature review. Dexamphetamine and LDX, a prodrug of dexamphetamine, are indicated for the treatment of attention-deficit/hyperactivity disorder. It has been suggested that LDX may have a reduced potential for oral…

    📄 PubMed で読む (PMID: 39024047)
  • Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis.

    Spyridon Siafis, Oğulcan Çıray, Hui Wu 他 · Molecular autism · 2022

    There is still no approved medication for the core symptoms of autism spectrum disorder (ASD). This network meta-analysis investigated pharmacological and dietary-supplement treatments for ASD. We searched for randomized-controlled-trials (RCTs) with a minimum duration of seven days in ClinicalTrials.gov, EMBASE, MEDLINE, PsycINFO, WHO-ICTRP (from inception up to July 8, 2018), CENTRAL and PubMed …

    📄 PubMed で読む (PMID: 35246237)
  • Comparative cardiovascular safety of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.

    Luis C Farhat, Alice Lannes, Cinzia Del Giovane 他 · The lancet. Psychiatry · 2025

    Concerns about the cardiovascular safety of medications used for the treatment of attention-deficit hyperactivity disorder (ADHD) remain. We aimed to compare the effects of pharmacological treatments for ADHD on haemodynamic values and electrocardiogram (ECG) parameters in children, adolescents, and adults. For this systematic review and network meta-analysis, we searched 12 electronic databases, …

    📄 PubMed で読む (PMID: 40203844)
  • A Randomized, Phase 3, Double-Blind, Crossover Comparison of Multilayer, Extended-Release Methylphenidate (PRC-063), and Lisdexamfetamine in the Driving Performance of Young Adults With ADHD.

    Vishal Madaan, Sailaja Bhaskar, Graeme A E Donnelly 他 · Journal of attention disorders · 2024

    To compare PRC-063 (multilayer-release methylphenidate) and lisdexamfetamine dimesylate (LDX) on the driving performance of young adults with attention deficit hyperactivity disorder (ADHD) in a randomized, double-blind, crossover study. Following up to 21 days of each treatment in each treatment course (PRC-063/LDX or LDX/PRC-063), subjects completed a 15-hour driving simulator laboratory assessm…

    📄 PubMed で読む (PMID: 38404033)
  • Efficacy and safety of pharmacological treatments in borderline personality disorder: A systematic review and network meta-analysis.

    Cyril Gerolymos, Alexandra Garosi, Laurent Boyer 他 · Molecular psychiatry · 2026

    Patients with borderline personality disorder (BPD) are over-represented in psychiatric services, and their suicide mortality is markedly higher than that of the general population. This network meta-analysis evaluated and compared the efficacy and safety of pharmacological treatments for symptoms of BPD. A systematic search of Medline®, Web of Science®, and Google Scholar® identified randomised c…

    📄 PubMed で読む (PMID: 41667836)
  • Occurrence of Psychosis and Bipolar Disorder in Individuals With Attention-Deficit/Hyperactivity Disorder Treated With Stimulants: A Systematic Review and Meta-Analysis.

    Gonzalo Salazar de Pablo, Claudia Aymerich, Juan Pablo Chart-Pascual 他 · JAMA psychiatry · 2025

    Individuals with attention-deficit/hyperactivity disorder (ADHD) may present with psychosis or bipolar disorder (BD) following treatment with stimulants. The extent to which this occurs is currently unclear. To meta-analytically quantify the occurrence of psychosis or BD after exposure to stimulants in individuals with ADHD and assess possible moderating factors. PubMed, Web of Science, Ovid/PsycI…

    📄 PubMed で読む (PMID: 40900605)
  • Safety of Treatments for ADHD in Adults: Pairwise and Network Meta-Analyses.

    Danielly Chierrito de Oliveira, Patricia Guerrero de Sousa, Camila Borges Dos Reis 他 · Journal of attention disorders · 2019

    The aim of the study was to analyze evidence comparing the profile of drugs used to treat ADHD in adult patients. Systematic searches were conducted in electronic databases. Randomized, double-blind, parallel controlled trials that evaluated the safety of drugs in ADHD were included. The statistical analyses were conducted by pairwise meta-analyses and mixed treatment comparison (MTC). Ten ( n = 3…

    📄 PubMed で読む (PMID: 28366111)
  • An Evaluation on the Efficacy and Safety of Treatments for Attention Deficit Hyperactivity Disorder in Children and Adolescents: a Comparison of Multiple Treatments.

    Ying Li, Jie Gao, Shu He 他 · Molecular neurobiology · 2017

    Attention deficit hyperactivity disorder (ADHD) is one of the most common neurobehavioral disorders. We carried out this comparison of multiple treatments based on sufficient data in attempt to evaluate the efficacy and safety of ADHD medication for children and adolescents. PubMed, Embase and the Cochrane Database were used to search for relevant articles. Changes in the ADHD Rating Scale (ADHD-R…

    📄 PubMed で読む (PMID: 27738872)
  • Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.

    Rebecca Rodrigues, Meng-Chuan Lai, Adam Beswick 他 · Journal of child psychology and psychiatry, and allied disciplines · 2021

    Clinically significant attention-deficit/hyperactivity disorder (ADHD) symptoms are common and impairing in children and youth with autism spectrum disorder(ASD). The aim of this systematic review and meta-analysis was to (a) evaluate the efficacy and safety of pharmacotherapy for the treatment of ADHD symptoms in ASD and (b) distil findings for clinical translation. We searched electronic databas…

    📄 PubMed で読む (PMID: 32845025)